These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27757764)

  • 1. Application of GPCR Structures for Modelling of Free Fatty Acid Receptors.
    Tikhonova IG
    Handb Exp Pharmacol; 2017; 236():57-77. PubMed ID: 27757764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acid receptors: structural models and elucidation of ligand binding interactions.
    Tikhonova IG; Poerio E
    BMC Struct Biol; 2015 Sep; 15():16. PubMed ID: 26346819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of free fatty acid receptors in the regulation of energy metabolism.
    Hara T; Kashihara D; Ichimura A; Kimura I; Tsujimoto G; Hirasawa A
    Biochim Biophys Acta; 2014 Sep; 1841(9):1292-300. PubMed ID: 24923869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids.
    Stoddart LA; Smith NJ; Jenkins L; Brown AJ; Milligan G
    J Biol Chem; 2008 Nov; 283(47):32913-24. PubMed ID: 18801738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.
    Milligan G; Stoddart LA; Smith NJ
    Br J Pharmacol; 2009 Sep; 158(1):146-53. PubMed ID: 19719777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.
    Ulven T
    Front Endocrinol (Lausanne); 2012; 3():111. PubMed ID: 23060857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the ligand recognition and signaling of free fatty acid receptors.
    Zhang X; Guseinov AA; Jenkins L; Li K; Tikhonova IG; Milligan G; Zhang C
    Sci Adv; 2024 Jan; 10(2):eadj2384. PubMed ID: 38198545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
    Milligan G; Alvarez-Curto E; Watterson KR; Ulven T; Hudson BD
    Br J Pharmacol; 2015 Jul; 172(13):3254-65. PubMed ID: 25131623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key Questions for Translation of FFA Receptors: From Pharmacology to Medicines.
    Suckow AT; Briscoe CP
    Handb Exp Pharmacol; 2017; 236():101-131. PubMed ID: 27873087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.
    Takeuchi M; Hirasawa A; Hara T; Kimura I; Hirano T; Suzuki T; Miyata N; Awaji T; Ishiguro M; Tsujimoto G
    Br J Pharmacol; 2013 Apr; 168(7):1570-83. PubMed ID: 22639973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders.
    Moniri NH
    Biochem Pharmacol; 2016 Jun; 110-111():1-15. PubMed ID: 26827942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells.
    Karmokar PF; Moniri NH
    Biochem Pharmacol; 2022 Dec; 206():115328. PubMed ID: 36309079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3.
    Schmidt J; Smith NJ; Christiansen E; Tikhonova IG; Grundmann M; Hudson BD; Ward RJ; Drewke C; Milligan G; Kostenis E; Ulven T
    J Biol Chem; 2011 Mar; 286(12):10628-40. PubMed ID: 21220428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the ligand recognition and signaling of free fatty acid receptors.
    Zhang X; Guseinov AA; Jenkins L; Li K; Tikhonova IG; Milligan G; Zhang C
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free Fatty Acid Receptors and Cancer: From Nutrition to Pharmacology.
    Hopkins MM; Meier KE
    Handb Exp Pharmacol; 2017; 236():233-251. PubMed ID: 27757756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3.
    Hudson BD; Tikhonova IG; Pandey SK; Ulven T; Milligan G
    J Biol Chem; 2012 Nov; 287(49):41195-209. PubMed ID: 23066016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of the free fatty acids receptor-1 and -4 (FFA1/GPR40 and FFA4/GPR120) in bovine endometrial cells.
    Valenzuela P; Teuber S; Manosalva C; Alarcón P; Figueroa CD; Ratto M; Burgos RA; Hidalgo MA
    Vet Res Commun; 2019 Aug; 43(3):179-186. PubMed ID: 31187404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acid receptors and their role in regulation of energy metabolism.
    Hara T; Kimura I; Inoue D; Ichimura A; Hirasawa A
    Rev Physiol Biochem Pharmacol; 2013; 164():77-116. PubMed ID: 23625068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeutics.
    Yonezawa T; Kurata R; Yoshida K; Murayama MA; Cui X; Hasegawa A
    Curr Med Chem; 2013; 20(31):3855-71. PubMed ID: 23862620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.